Hormone shot timing may affect recovery after prostate cancer treatment
NCT ID NCT00175383
First seen Jul 02, 2026 · Last updated Jul 02, 2026
Summary
This trial compares two types of hormone injections given before prostate brachytherapy (internal radiation) for early-stage prostate cancer. One injection lasts one month, the other three months, and both are used to lower testosterone to make radiation more effective. The study measures how quickly testosterone returns to normal after treatment, as well as PSA levels, quality of life, and sexual function. Participants are men with localized prostate cancer who are already recommended to receive hormone therapy as part of their brachytherapy plan.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
LHRH agonist (short-acting or long-acting injection)
What this could lead to
If one type allows faster testosterone recovery, it could help men regain normal hormone levels sooner after prostate cancer treatment.
What could go wrong
This is a small, single-center study comparing two drug schedules, not testing a new treatment. Results may not change standard care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- AMPLIFI: Web-Based Lifestyle Program for Cancer NCT04000880
- Comparing Radiotherapy Techniques for Pelvic Can NCT01325961
- ToP-RAP: Urethra-Sparing Prostatectomy Trial (NCT07678489)
- 177Lu-PSMA-617 & Darolutamide for Prostate Cance NCT07677566
- Fasting or Ketones for Prostate Cancer NCT06826924
- Darolutamide for High-Risk Prostate Cancer Trial NCT05171387
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
BC Cancer Agency - Vancouver Island Centre
Victoria, British Columbia, V8R 6V5, Canada